Epitomee Medical Ltd
TASE:EPIT
Intrinsic Value
The intrinsic value of one EPIT stock under the Base Case scenario is 21.65 ILS. Compared to the current market price of 970 ILS, Epitomee Medical Ltd is Overvalued by 98%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Epitomee Medical Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Epitomee Medical Ltd
Balance Sheet Decomposition
Epitomee Medical Ltd
Current Assets | 22.5m |
Cash & Short-Term Investments | 22.1m |
Receivables | 388k |
Other Current Assets | 16k |
Non-Current Assets | 17.7m |
PP&E | 17.4m |
Other Non-Current Assets | 294k |
Free Cash Flow Analysis
Epitomee Medical Ltd
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Epitomee Medical Ltd
Revenue
|
0
USD
|
Operating Expenses
|
-2m
USD
|
Operating Income
|
-2m
USD
|
Other Expenses
|
538k
USD
|
Net Income
|
-1.5m
USD
|
EPIT Profitability Score
Profitability Due Diligence
Epitomee Medical Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Epitomee Medical Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
EPIT Solvency Score
Solvency Due Diligence
Epitomee Medical Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Epitomee Medical Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EPIT Price Targets Summary
Epitomee Medical Ltd
Dividends
Current shareholder yield for EPIT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one EPIT stock under the Base Case scenario is 21.65 ILS.
Compared to the current market price of 970 ILS, Epitomee Medical Ltd is Overvalued by 98%.